Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy - PubMed (original) (raw)
. 2015 Apr;21(4):395-400.
doi: 10.1038/nm.3824. Epub 2015 Mar 23.
Woo-il Kim 1, Hoon-Chul Kang 2, Se Hoon Kim 3, Ah Hyung Park 4, Eun Kyung Park 5, Young-Wook Cho 6, Sangwoo Kim 7, Ho Min Kim 1, Jeong A Kim 2, Junho Kim 7, Hwanseok Rhee 8, Seok-Gu Kang 5, Heung Dong Kim 2, Daesoo Kim 4, Dong-Seok Kim 5, Jeong Ho Lee 1
Affiliations
- PMID: 25799227
- DOI: 10.1038/nm.3824
Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy
Jae Seok Lim et al. Nat Med. 2015 Apr.
Abstract
Focal cortical dysplasia type II (FCDII) is a sporadic developmental malformation of the cerebral cortex characterized by dysmorphic neurons, dyslamination and medically refractory epilepsy. It has been hypothesized that FCD is caused by somatic mutations in affected regions. Here, we used deep whole-exome sequencing (read depth, 412-668×) validated by site-specific amplicon sequencing (100-347,499×) in paired brain-blood DNA from four subjects with FCDII and uncovered a de novo brain somatic mutation, mechanistic target of rapamycin (MTOR) c.7280T>C (p.Leu2427Pro) in two subjects. Deep sequencing of the MTOR gene in an additional 73 subjects with FCDII using hybrid capture and PCR amplicon sequencing identified eight different somatic missense mutations found in multiple brain tissue samples of ten subjects. The identified mutations accounted for 15.6% of all subjects with FCDII studied (12 of 77). The identified mutations induced the hyperactivation of mTOR kinase. Focal cortical expression of mutant MTOR by in utero electroporation in mice was sufficient to disrupt neuronal migration and cause spontaneous seizures and cytomegalic neurons. Inhibition of mTOR with rapamycin suppressed cytomegalic neurons and epileptic seizures. This study provides, to our knowledge, the first evidence that brain somatic activating mutations in MTOR cause FCD and identifies mTOR as a treatment target for intractable epilepsy in FCD.
Similar articles
- Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
Lim JS, Gopalappa R, Kim SH, Ramakrishna S, Lee M, Kim WI, Kim J, Park SM, Lee J, Oh JH, Kim HD, Park CH, Lee JS, Kim S, Kim DS, Han JM, Kang HC, Kim HH, Lee JH. Lim JS, et al. Am J Hum Genet. 2017 Mar 2;100(3):454-472. doi: 10.1016/j.ajhg.2017.01.030. Epub 2017 Feb 16. Am J Hum Genet. 2017. PMID: 28215400 Free PMC article. - Brain somatic mutations in MTOR leading to focal cortical dysplasia.
Lim JS, Lee JH. Lim JS, et al. BMB Rep. 2016 Feb;49(2):71-2. doi: 10.5483/bmbrep.2016.49.2.010. BMB Rep. 2016. PMID: 26779999 Free PMC article. - A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II.
Zhao S, Li Z, Zhang M, Zhang L, Zheng H, Ning J, Wang Y, Wang F, Zhang X, Gan H, Wang Y, Zhang X, Luo H, Bu G, Xu H, Yao Y, Zhang YW. Zhao S, et al. Exp Mol Med. 2019 Jul 23;51(7):1-11. doi: 10.1038/s12276-019-0277-4. Exp Mol Med. 2019. PMID: 31337748 Free PMC article. - Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS, Baldassari S, Stephenson SEM, Lockhart PJ, Baulac S, Leventer RJ. Lee WS, et al. Int J Mol Sci. 2022 Jan 25;23(3):1344. doi: 10.3390/ijms23031344. Int J Mol Sci. 2022. PMID: 35163267 Free PMC article. Review. - Somatic mutations rather than viral infection classify focal cortical dysplasia type II as mTORopathy.
Blümcke I, Sarnat HB. Blümcke I, et al. Curr Opin Neurol. 2016 Jun;29(3):388-95. doi: 10.1097/WCO.0000000000000303. Curr Opin Neurol. 2016. PMID: 26840044 Review.
Cited by
- Polymers as Efficient Non-Viral Gene Delivery Vectors: The Role of the Chemical and Physical Architecture of Macromolecules.
Khan M. Khan M. Polymers (Basel). 2024 Sep 18;16(18):2629. doi: 10.3390/polym16182629. Polymers (Basel). 2024. PMID: 39339093 Free PMC article. Review. - Low-level brain somatic mutations in exonic regions are collectively implicated in autism with germline mutations in autism risk genes.
Kim IB, Kim MH, Jung S, Kim WK, Lee J, Ju YS, Webster MJ, Kim S, Kim JH, Kim HJ, Kim J, Kim S, Lee JH. Kim IB, et al. Exp Mol Med. 2024 Aug;56(8):1750-1762. doi: 10.1038/s12276-024-01284-1. Epub 2024 Aug 1. Exp Mol Med. 2024. PMID: 39085355 Free PMC article. - Clinical and functional studies of MTOR variants in Smith-Kingsmore syndrome reveal deficits of circadian rhythm and sleep-wake behavior.
Liu AC, Shen Y, Serbinski CR, He H, Roman D, Endale M, Aschbacher-Smith L, King KA, Granadillo JL, López I, Krueger DA, Dye TJ, Smith DF, Hogenesch JB, Prada CE. Liu AC, et al. HGG Adv. 2024 Oct 10;5(4):100333. doi: 10.1016/j.xhgg.2024.100333. Epub 2024 Jul 17. HGG Adv. 2024. PMID: 39030910 Free PMC article. - [(Auto)immunity in focal epilepsy: mechanisms of (auto‑)immune-inflammatory epileptogenic neurodegeneration].
Melzer N, Weber K, Räuber S, Rosenow F. Melzer N, et al. Nervenarzt. 2024 Oct;95(10):932-937. doi: 10.1007/s00115-024-01695-5. Epub 2024 Jul 2. Nervenarzt. 2024. PMID: 38953922 Free PMC article. Review. German. - Broadening the scope of multigene panel analysis for adult epilepsy patients.
Lee S, Kang MK, So KH, Jang R, Shin YW, Jang SS, Yoon JG, Kim S, Kim M, Chu K, Lee SK, Kim KJ, Baek ST, Lim BC, Moon J. Lee S, et al. Epilepsia Open. 2024 Aug;9(4):1538-1549. doi: 10.1002/epi4.12993. Epub 2024 Jul 1. Epilepsia Open. 2024. PMID: 38946282 Free PMC article.
References
- N Engl J Med. 2013 May 23;368(21):1971-9 - PubMed
- Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3514-9 - PubMed
- Ann Neurol. 2004 Oct;56(4):478-87 - PubMed
- Neuron. 2012 Apr 12;74(1):41-8 - PubMed
- Science. 2013 Jul 5;341(6141):1237758 - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous